findmyKOL

Paul Celano, MD

Basic profile

Greater Baltimore Medical Center

ORCIDNPI
RegionBaltimore, MD · NortheastSpecialtyMedical OncologyFocusOncology
Last active 1993findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1990–1993Why? →

Paul Celano is an Oncology physician affiliated with Greater Baltimore Medical Center. OpenAlex indexes 44 publications with 5,783 citations (h-index 23).

Overview

Scholarship

indexed output and impact (OpenAlex)
44publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,783citations

Total citations across indexed works.

23h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1NIH grants · 1990–1993

Federally funded research awards.

View funding

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    68.5%
    Integrin Receptor Antagonist37.6%
    Vedolizumab100%
    Part B, office-administered11 patients
    PD-1 inhibitor30.1%
    Pembrolizumab100%
    Part B, office-administered15 patients

    + 6 more classes in this area

  • Metabolism & gastrointestinal

    14%
    Other antiemetics12.5%
    Fosaprepitant100%
    Part B, office-administered14 patients
    Serotonin-3 Receptor Antagonist1.4%
    Palonosetron hcl100%
    Part B, office-administered21 patients

    + 1 more class in this area

  • Musculoskeletal

    13%
    RANK Ligand Inhibitor12.2%
    Denosumab100%
    Part B, office-administered20 patients
    Bisphosphonate0.8%
    Zoledronic acid100%
    Part B, office-administered85 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 19901993 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”